Connor, Clark & Lunn Investment Management »

Kinnate Biopharma shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Kinnate Biopharma (KNTE) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Kinnate Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Kinnate Biopharma held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kinnate Biopharma by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $182k 77k 2.37
2023-09-30 $73k 52k 1.40